Download PDF
Thromb Haemost 1998; 80(01): 206-207
DOI: 10.1055/s-0037-1615169
Letters to the Editor
Schattauer GmbH

Idiopathic Versus Secondary Thrombosis as a Predictive Marker of Occult Malignancy

Antonio Girolami
1   Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 18 February 1998

Accepted 02 March 1998

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, Julian J. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.. Thromb Haemost 1998; 79: 19-22.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, Piovella F. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.. Thromb Haemost 1995; 74: 606-11.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer.. Cancer 1986; 57: 1846-9.
    CrossrefPubMedSearch in Google Scholar
  • 4 Monreal M, Salvador R, Soriano V, Sabria M. Cancer and deep vein thrombosis.. Arch Intern Med 1988; 148: 485.
    CrossrefPubMedSearch in Google Scholar
  • 5 Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, Martorellet A. Occult cancer in patients with deep venous thrombosis: a systematic approach.. Cancer 1991; 67: 541-5.
    CrossrefPubMedSearch in Google Scholar
  • 6 Prandoni P, Lensing AWA, Büller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.. N Engl J Med 1992; 327: 1128-33.
    CrossrefPubMedSearch in Google Scholar
  • 7 Monreal M, Casals A, Boix J, Olazabal A, Montserrat E, Ribas Mundo M. Occult cancer in patients with acute pulmonary embolism. A prospective study.. Chest 1993; 103: 816-9.
    CrossrefPubMedSearch in Google Scholar
  • 8 Bastounis EA, Karayannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study.. J Intern Med 1996; 239: 153-6.
    CrossrefPubMedSearch in Google Scholar
  • 9 Ahmed Z, Mohuddin Z. Deep vein thrombosis as a predictor of cancer.. Angiology 1996; 47: 261-5.
    CrossrefPubMedSearch in Google Scholar
  • 10 Hettiarachchi RJK, Prins MH, Büller HR, Prandoni P, ten Cate JW. Occult malignancy in patients with deep-vein thrombosis. Incidence and risk indicators.. Thromb Haemost 1998 (Suppl.) OC-1563.
    PubMedSearch in Google Scholar
  • 11 Achkar A, Laaban JP, Horellou MH, Rabbat A, Conard J, Nataf J. Prospective screening for occult cancer in patients with venous thromboembolism.. Thromb Haemost 1998 (Suppl) OC-1564.
    PubMedSearch in Google Scholar
  • 12 Monreal M, Fernandez-Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E. Occult cancer in patients with venous thromboembolism: which patients, which cancers.. Thromb Haemost 1998; 78: 1316-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 13 Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH, Bossuyt PMM, de Haes H, van den Belt AGM, Sagnard L, D’Azemar P, Büller HR. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.. N Engl J Med 1996; 334: 682-7.
    CrossrefPubMedSearch in Google Scholar
  • 14 Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep vein thrombosis.. Ann Intern Med 1996; 125: 785-93.
    CrossrefPubMedSearch in Google Scholar
  • 15 Nordstrom M, Linblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep vein thrombosis and occult malignancy: an epidemiological study.. Mr Med J 1994; 308: 891-4.
    PubMedSearch in Google Scholar
  • 16 The Columbus Investigators.. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.. N Engl J Med 1998; 337: 657-62.
    PubMedSearch in Google Scholar
  • 17 Prandoni P. Antithrombotic strategies in patients with cancer.. Thromb Haemost 1998; 78: 141-4.
    Thieme ConnectPubMedSearch in Google Scholar
  • 18 Piccioli A, Lensing AWA, Prandoni P. Screening for occult malignancy in patients with idiopathic venous thromboembolism (SOMIT). Study design.. Thromb Haemost 1998 (Suppl.) PS-489.
    PubMedSearch in Google Scholar